Can Daewoong’s P-CAB Unsettle Competition?
Company Seeking Partnerships For Markets Such As China And The US
Daewoong Pharmaceutical has successfully completed a Phase III clinical trial of next generation gastroesophageal reflux disease (GERD) drug candidate in South Korea, but strong competition awaits from approved P-CAB drugs of CJ Healthcare and Takeda.
